rs199854166

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS1

The NM_152296.5(ATP1A3):​c.*236T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000382 in 1,531,030 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.00042 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00038 ( 1 hom. )

Consequence

ATP1A3
NM_152296.5 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: -0.371

Publications

0 publications found
Variant links:
Genes affected
ATP1A3 (HGNC:801): (ATPase Na+/K+ transporting subunit alpha 3) The protein encoded by this gene belongs to the family of P-type cation transport ATPases, and to the subfamily of Na+/K+ -ATPases. Na+/K+ -ATPase is an integral membrane protein responsible for establishing and maintaining the electrochemical gradients of Na and K ions across the plasma membrane. These gradients are essential for osmoregulation, for sodium-coupled transport of a variety of organic and inorganic molecules, and for electrical excitability of nerve and muscle. This enzyme is composed of two subunits, a large catalytic subunit (alpha) and a smaller glycoprotein subunit (beta). The catalytic subunit of Na+/K+ -ATPase is encoded by multiple genes. This gene encodes an alpha 3 subunit. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]
ATP1A3 Gene-Disease associations (from GenCC):
  • alternating hemiplegia of childhood 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • ATP1A3-associated neurological disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
  • cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • developmental and epileptic encephalopathy 99
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • dystonia 12
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • encephalopathy, acute, infection-induced
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • alternating hemiplegia of childhood
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 19-41966701-A-G is Benign according to our data. Variant chr19-41966701-A-G is described in ClinVar as Benign. ClinVar VariationId is 329398.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000423 (62/146538) while in subpopulation AMR AF = 0.000143 (2/13986). AF 95% confidence interval is 0.0000697. There are 0 homozygotes in GnomAd4. There are 27 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_152296.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP1A3
NM_152296.5
MANE Select
c.*236T>C
3_prime_UTR
Exon 23 of 23NP_689509.1P13637-1
ATP1A3
NM_001256214.2
c.*236T>C
3_prime_UTR
Exon 23 of 23NP_001243143.1P13637-3
ATP1A3
NM_001256213.2
c.*236T>C
3_prime_UTR
Exon 23 of 23NP_001243142.1P13637-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP1A3
ENST00000648268.1
MANE Select
c.*236T>C
3_prime_UTR
Exon 23 of 23ENSP00000498113.1P13637-1
ENSG00000285505
ENST00000644613.1
n.3013+548T>C
intron
N/AENSP00000494711.1A0A2R8YEY8
ATP1A3
ENST00000545399.6
TSL:2
c.*236T>C
3_prime_UTR
Exon 23 of 23ENSP00000444688.1P13637-3

Frequencies

GnomAD3 genomes
AF:
0.000423
AC:
62
AN:
146538
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000760
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000143
Gnomad ASJ
AF:
0.0139
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000134
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000793
AC:
120
AN:
151260
AF XY:
0.000727
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000366
Gnomad ASJ exome
AF:
0.0110
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000262
Gnomad OTH exome
AF:
0.000925
GnomAD4 exome
AF:
0.000378
AC:
523
AN:
1384492
Hom.:
1
Cov.:
31
AF XY:
0.000362
AC XY:
247
AN XY:
682590
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31228
American (AMR)
AF:
0.000397
AC:
14
AN:
35224
Ashkenazi Jewish (ASJ)
AF:
0.0120
AC:
299
AN:
24866
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35048
South Asian (SAS)
AF:
0.0000256
AC:
2
AN:
78214
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
46602
Middle Eastern (MID)
AF:
0.000714
AC:
4
AN:
5606
European-Non Finnish (NFE)
AF:
0.000121
AC:
129
AN:
1070432
Other (OTH)
AF:
0.00131
AC:
75
AN:
57272
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
25
51
76
102
127
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000423
AC:
62
AN:
146538
Hom.:
0
Cov.:
31
AF XY:
0.000381
AC XY:
27
AN XY:
70944
show subpopulations
African (AFR)
AF:
0.0000760
AC:
3
AN:
39456
American (AMR)
AF:
0.000143
AC:
2
AN:
13986
Ashkenazi Jewish (ASJ)
AF:
0.0139
AC:
48
AN:
3442
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4910
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4644
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9638
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
298
European-Non Finnish (NFE)
AF:
0.000134
AC:
9
AN:
67266
Other (OTH)
AF:
0.00
AC:
0
AN:
2000
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00144
Hom.:
0
Bravo
AF:
0.000499

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Alternating hemiplegia of childhood 2 (1)
-
-
1
Dystonia 12 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
2.0
DANN
Benign
0.47
PhyloP100
-0.37

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199854166; hg19: chr19-42470853; API